Human Reproduction, Vol. 16, No. 12, 2587-2592,
December 2001
© 2001 European Society of Human Reproduction and Embryology
Natural cycle IVF in unexplained, endometriosis-associated and tubal factor infertility
Department of Obstetrics and Gynaecology, National Hospital, University of Oslo, Oslo, Norway
BACKGROUND: To elucidate possible differences between unexplained and minimal peritoneal endometriosis-associated infertility, we studied their outcome in natural cycle IVF (NIVF). METHODS: A prospective cohort study was carried out on unexplained (33 couples), minimal peritoneal endometriosis-associated (30 couples) and tubal factor (24 couples) infertility in 223 NIVF cycles, using human chorionic gonadotrophin (HCG) for ovulation induction. RESULTS: During the first NIVF attempt, follicular and luteal phase oestradiol, FSH, LH and progesterone concentrations, as well as endometrial thickness and follicular diameter were similar among the three groups. Periovulatory follicular growth monitored from day of HCG administration to oocyte aspiration was significantly lowered in unexplained infertility compared with minimal endometriosis-associated and tubal factor infertility. The fertilization rate, clinical pregnancy rate per initiated cycle, per successful oocyte retrieval and per embryo transfer, in minimal endometriosis (80.0, 10.4, 16.0 and 23.5% respectively) were similar to that in tubal factor infertility patients (68.6, 5.8, 11.4 and 16.0%) but significantly higher (P < 0.05) than that of the unexplained infertility group (62.2, 2.6, 5.4 and 8.7%). CONCLUSIONS: The significant reduction in follicular periovulatory growth, fertilization and pregnancy rates in unexplained infertility compared with minimal peritoneal endometriosis patients may be explained by sub-optimal follicular development with possibly reduced oocyte quality, intrinsic embryo quality factors or by impaired implantation. From a clinical point of view, NIVF is less suited to unexplained infertility treatment, but might represent an interesting treatment option for minimal peritoneal endometriosis-associated infertility.
Key words: natural cycle/IVF/endometriosis/unexplained infertility/tubal factor
1 To whom correspondence should be addressed. E-mail: anne.omland{at}rikshospitalet.no
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  L. Aghajanova, K. Bjuresten, S. Altmae, B.-M. Landgren, and A. Stavreus-Evers HB-EGF but Not Amphiregulin or Their Receptors HER1 and HER4 Is Altered in Endometrium of Women With Unexplained Infertility Reproductive Sciences, May 1, 2008; 15(5): 484 - 492. [Abstract] [PDF]
|
|
|
|
 |
|
 M.J. Pelinck, N.E.A. Vogel, A. Hoek, A.H.M. Simons, E.G.J.M. Arts, M.H. Mochtar, S. Beemsterboer, M.N. Hondelink, and M.J. Heineman Cumulative pregnancy rates after three cycles of minimal stimulation IVF and results according to subfertility diagnosis: a multicentre cohort study Hum. Reprod., September 1, 2006; 21(9): 2375 - 2383. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Sonmezer and K. Oktay Fertility preservation in young women undergoing breast cancer therapy. Oncologist, May 1, 2006; 11(5): 422 - 434. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Sifer, T. Sasportes, V. Barraud, C. Poncelet, J. Rudant, R. Porcher, I. Cedrin-Durnerin, B. Martin-Pont, J.N. Hugues, and J.P. Wolf World Health Organization grade 'a' motility and zona-binding test accurately predict IVF outcome for mild male factor and unexplained infertilities Hum. Reprod., October 1, 2005; 20(10): 2769 - 2775. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. K. Omland, T. Abyholm, P. Fedorcsak, G. Ertzeid, N. B. Oldereid, S. Bjercke, and T. Tanbo Pregnancy outcome after IVF and ICSI in unexplained, endometriosis-associated and tubal factor infertility Hum. Reprod., March 1, 2005; 20(3): 722 - 727. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M.J. Pelinck, N.E.A. Vogel, A. Hoek, E.G.J.M. Arts, A.H.M. Simons, and M.J. Heineman Minimal stimulation IVF with late follicular phase administration of the GnRH antagonist cetrorelix and concomitant substitution with recombinant FSH: a pilot study Hum. Reprod., March 1, 2005; 20(3): 642 - 648. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Ombelet, P. De Sutter, J. Van der Elst, and G. Martens Multiple gestation and infertility treatment: registration, reflection and reaction--the Belgian project Hum. Reprod. Update, January 1, 2005; 11(1): 3 - 14. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Oktay, E. Buyuk, O. Davis, I. Yermakova, L. Veeck, and Z. Rosenwaks Fertility preservation in breast cancer patients: IVF and embryo cryopreservation after ovarian stimulation with tamoxifen Hum. Reprod., January 1, 2003; 18(1): 90 - 95. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. D. Keay and D. J. Cahill Different aetiological mechanisms for unexplained and endometriosis-associated infertility cannot be inferred from unstimulated IVF cycles using HCG to induce ovulation Hum. Reprod., July 1, 2002; 17(7): 1926 - 1927. [Full Text] [PDF]
|
|
|
|
|
|
A.K. Omland, P. Fedorcsak, R. Storeng, P.O. Dale, T. Abyholm, and T. Tanbo Different aetiological mechanisms for unexplained and endometriosis-associated infertility cannot be inferred from unstimulated IVF cycles using HCG to induce ovulation Hum. Reprod., July 1, 2002; 17(7): 1927 - 1927. [Full Text]
|
|